DJIA 16,160.20 101.85 0.63%
NASDAQ 4,668.25 32.15 0.69%
S&P 500 1,923.97 10.12 0.53%
market minute promo

Gilead Sciences (NASDAQ: GILD)

101.96 0.47 (0.46%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $101.97 0.47%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $103.44
Previous Close $101.49
Daily Range $101.77 - $103.53
52-Week Range $85.95 - $123.37
Market Cap $149.6B
P/E Ratio 10.67
Dividend (Yield) $1.72 (1.7%)
Ex-Dividend Date
Dividend Pay Date
09/14/15
09/29/15
Volume 2,331,408
Average Daily Volume 11,602,513
Current FY EPS $11.99

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

5 Top Stocks to Buy in September

These stocks represent five unique takes on potentially incredible long-term value. Dive in to see how Netflix, Oshkosh, TrueCar, Universal Display, and Gilead Sciences can help you.

Strength Seen in Trevena (TRVN): Stock Surges 51.5%

Biotech Stock Roundup: Amgen in the News, ARIAD a Takeover Target?

The Market Peak Is In

How To Be Greedy When Others Are Fearful, 5%+ Dividend Yield Portfolio Trades For August 2015

Intercept's (ICPT) OCA Under Priority Review in the U.S.

Amicus (FOLD) Signs Agreement to Acquire Scioderm

Despite Strong U.S. Data, Chinese Economic Woes Weigh on Stocks

How To Handle Market Crashes

Trade-Ideas: Gilead (GILD) Is Today's Pre-Market Laggard Stock

See More GILD News...

GILD's Top Competitors

GILD $101.96 (0.46%)
Current stock: GILD
AMGN $148.40 (0.64%)
Current stock: AMGN
CELG $116.80 (1.16%)
Current stock: CELG
$0.00 (0.00%)
Current stock: